Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance.
- NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_assertion description "[Systemic treatment with Ad-deltaE1B-RLX completely inhibited the growth of Hep1 hepatocellular carcinomas (PBS = 20.2 mg of tumor per mouse and Ad-deltaE1B-RLX = 0 mg; difference = 20.2 mg, 95% CI = 3.7 to 36.7; P = .004, Mann-Whitney test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance.
- NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_assertion evidence source_evidence_literature NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance.
- NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_assertion SIO_000772 17047197 NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance.
- NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_assertion wasDerivedFrom befree-20140225 NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance.
- NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_assertion wasGeneratedBy ECO_0000203 NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP778550.RACiw9b1JklXP30SXg84-loCIQpnQjFw9qhhnz2lMRHLo130_provenance.